BioInfra Co., Ltd. (KOSDAQ:199730)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,510.00
-21.00 (-1.37%)
At close: Sep 3, 2026

BioInfra Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,8292,1444,03210,6947,3625,782
Short-Term Investments
4,2106,0287,0284,011177.4400.99
Cash & Short-Term Investments
7,0398,17211,06014,7057,5396,183
Cash Growth
-27.88%-26.11%-24.79%95.04%21.94%-14.89%
Accounts Receivable
3,2301,7702,0473,0223,2613,860
Other Receivables
-53.7793.7596.690.16371.65
Receivables
3,2301,9302,2553,5253,5614,732
Prepaid Expenses
-113.863.0446.3941.9425.08
Other Current Assets
1,8811,9071,3863,1311,7252,158
Total Current Assets
12,15012,12214,76421,40812,86713,097
Property, Plant & Equipment
17,24518,02818,83318,86817,4137,865
Long-Term Investments
761.58702.292,4043,118414.91390.12
Other Intangible Assets
1,0811,1391,1521,210632.79367.63
Long-Term Deferred Tax Assets
2,3142,3403,3461,446706.751,123
Other Long-Term Assets
634.73623.51619.19943.89555.1310,896
Total Assets
34,18534,96141,12147,00432,58933,740

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1,3521,8131,1731,2031,9401,200
Accrued Expenses
-360.43311.286.5517.37354.49
Short-Term Debt
8,5006,5004,0004,000-2,800
Current Portion of Long-Term Debt
4,2004,200-15075.9898.64
Current Portion of Leases
438.67422.17413.29366.1598.61389.9
Current Income Taxes Payable
---17.68331.07149.89
Other Current Liabilities
6,4254,3703,3212,6633,4126,161
Total Current Liabilities
20,91617,6659,2198,4856,37511,154
Long-Term Debt
--4,2004,0508,20011,676
Long-Term Leases
601.86735.3356.18424.896.9347.25
Pension & Post-Retirement Benefits
10.249.191510.56-
Other Long-Term Liabilities
60.6959.5163.0159.532.250
Total Liabilities
21,58818,46913,55313,03014,68022,877

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
2,4322,4322,4322,3982,064687.89
Additional Paid-In Capital
6,5136,51314,51313,553335.871,718
Retained Earnings
2,5046,4589,53416,38814,3878,150
Comprehensive Income & Other
1,1481,0891,0891,6341,123306.3
Shareholders' Equity
12,59716,49127,56833,97417,91010,862
Total Liabilities & Equity
34,18534,96141,12147,00432,58933,740

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
13,74111,8578,6698,9918,47215,012
Net Cash (Debt)
-6,702-3,6862,3915,714-932.12-8,829
Net Cash Growth
---58.16%---
Net Cash Per Share
-1378.27-757.69493.031216.13-225.81-2138.51
Filing Date Shares Outstanding
5.044.864.864.84.134.13
Total Common Shares Outstanding
5.044.864.864.84.134.13
Working Capital
-8,766-5,5435,54612,9236,4921,943
Book Value Per Share
2497.203390.275667.397082.444334.862630.98
Tangible Book Value
11,51615,35226,41732,76417,27710,494
Tangible Book Value Per Share
2282.913156.065430.626830.264181.702541.94
Land
4,6184,6184,6184,6184,6182,173
Buildings
6,6026,6026,6026,6026,6023,099
Machinery
2,1072,0821,9541,5721,290605.76
Construction In Progress
-46.66----